The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Cord Blood Stem Cells-Global Market Insights and Sales Trends 2025
Synopsis
The global Cord Blood Stem Cells market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Cord Blood Stem Cells in various end use industries. The expanding demands from the Autoimmune Diseases, Immunodeficiencies, Malignancies,Caners and Solid Tumors, are propelling Cord Blood Stem Cells market. Allogeneic Stem Cell, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Autologous Stem Cell segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cord Blood Stem Cells, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Cord Blood Stem Cells market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Cord Blood Stem Cells market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cord Blood Stem Cells sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cord Blood Stem Cells covered in this report include Advanced Cell Technology, California Stem Cell, Cytori Therapeutics, Mesoblast Limited, Opexa Therapeutics Inc., Athersys Inc., Geron Corporation, Neostem Inc. and CBR Systems, Inc., etc.
The global Cord Blood Stem Cells market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Advanced Cell Technology
California Stem Cell
Cytori Therapeutics
Mesoblast Limited
Opexa Therapeutics Inc.
Athersys Inc.
Geron Corporation
Neostem Inc.
CBR Systems, Inc.
Cordlife
Cryo-Cell
Cryo-Save AG (A Group of Esperite)
Lifecell
Stemcyte
Viacord
Smart Cells International Ltd.
Cryoviva India
Cordvida
China Cord Blood Corporation
Global Cord Blood Stem Cells market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cord Blood Stem Cells market, Segment by Type:
Allogeneic Stem Cell
Autologous Stem Cell
Global Cord Blood Stem Cells market, by Application
Autoimmune Diseases
Immunodeficiencies
Malignancies,Caners
Solid Tumors
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Cord Blood Stem Cells companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Cord Blood Stem Cells market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Cord Blood Stem Cells in various end use industries. The expanding demands from the Autoimmune Diseases, Immunodeficiencies, Malignancies,Caners and Solid Tumors, are propelling Cord Blood Stem Cells market. Allogeneic Stem Cell, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Autologous Stem Cell segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cord Blood Stem Cells, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Cord Blood Stem Cells market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Cord Blood Stem Cells market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cord Blood Stem Cells sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cord Blood Stem Cells covered in this report include Advanced Cell Technology, California Stem Cell, Cytori Therapeutics, Mesoblast Limited, Opexa Therapeutics Inc., Athersys Inc., Geron Corporation, Neostem Inc. and CBR Systems, Inc., etc.
The global Cord Blood Stem Cells market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Advanced Cell Technology
California Stem Cell
Cytori Therapeutics
Mesoblast Limited
Opexa Therapeutics Inc.
Athersys Inc.
Geron Corporation
Neostem Inc.
CBR Systems, Inc.
Cordlife
Cryo-Cell
Cryo-Save AG (A Group of Esperite)
Lifecell
Stemcyte
Viacord
Smart Cells International Ltd.
Cryoviva India
Cordvida
China Cord Blood Corporation
Global Cord Blood Stem Cells market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cord Blood Stem Cells market, Segment by Type:
Allogeneic Stem Cell
Autologous Stem Cell
Global Cord Blood Stem Cells market, by Application
Autoimmune Diseases
Immunodeficiencies
Malignancies,Caners
Solid Tumors
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Cord Blood Stem Cells companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Cord Blood Stem Cells
1.1 Cord Blood Stem Cells Market Overview
1.1.1 Cord Blood Stem Cells Product Scope
1.1.2 Cord Blood Stem Cells Market Status and Outlook
1.2 Global Cord Blood Stem Cells Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Cord Blood Stem Cells Market Size by Region (2018-2029)
1.4 Global Cord Blood Stem Cells Historic Market Size by Region (2018-2023)
1.5 Global Cord Blood Stem Cells Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Cord Blood Stem Cells Market Size (2018-2029)
1.6.1 North America Cord Blood Stem Cells Market Size (2018-2029)
1.6.2 Europe Cord Blood Stem Cells Market Size (2018-2029)
1.6.3 Asia-Pacific Cord Blood Stem Cells Market Size (2018-2029)
1.6.4 Latin America Cord Blood Stem Cells Market Size (2018-2029)
1.6.5 Middle East & Africa Cord Blood Stem Cells Market Size (2018-2029)
2 Cord Blood Stem Cells Market by Type
2.1 Introduction
2.1.1 Allogeneic Stem Cell
2.1.2 Autologous Stem Cell
2.2 Global Cord Blood Stem Cells Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Cord Blood Stem Cells Historic Market Size by Type (2018-2023)
2.2.2 Global Cord Blood Stem Cells Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Cord Blood Stem Cells Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Cord Blood Stem Cells Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Cord Blood Stem Cells Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Cord Blood Stem Cells Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Cord Blood Stem Cells Revenue Breakdown by Type (2018-2029)
3 Cord Blood Stem Cells Market Overview by Application
3.1 Introduction
3.1.1 Autoimmune Diseases
3.1.2 Immunodeficiencies
3.1.3 Malignancies,Caners
3.1.4 Solid Tumors
3.1.5 Others
3.2 Global Cord Blood Stem Cells Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Cord Blood Stem Cells Historic Market Size by Application (2018-2023)
3.2.2 Global Cord Blood Stem Cells Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Cord Blood Stem Cells Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Cord Blood Stem Cells Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Cord Blood Stem Cells Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Cord Blood Stem Cells Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Cord Blood Stem Cells Revenue Breakdown by Application (2018-2029)
4 Cord Blood Stem Cells Competition Analysis by Players
4.1 Global Cord Blood Stem Cells Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cord Blood Stem Cells as of 2022)
4.3 Date of Key Players Enter into Cord Blood Stem Cells Market
4.4 Global Top Players Cord Blood Stem Cells Headquarters and Area Served
4.5 Key Players Cord Blood Stem Cells Product Solution and Service
4.6 Competitive Status
4.6.1 Cord Blood Stem Cells Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Advanced Cell Technology
5.1.1 Advanced Cell Technology Profile
5.1.2 Advanced Cell Technology Main Business
5.1.3 Advanced Cell Technology Cord Blood Stem Cells Products, Services and Solutions
5.1.4 Advanced Cell Technology Cord Blood Stem Cells Revenue (US$ Million) & (2018-2023)
5.1.5 Advanced Cell Technology Recent Developments
5.2 California Stem Cell
5.2.1 California Stem Cell Profile
5.2.2 California Stem Cell Main Business
5.2.3 California Stem Cell Cord Blood Stem Cells Products, Services and Solutions
5.2.4 California Stem Cell Cord Blood Stem Cells Revenue (US$ Million) & (2018-2023)
5.2.5 California Stem Cell Recent Developments
5.3 Cytori Therapeutics
5.3.1 Cytori Therapeutics Profile
5.3.2 Cytori Therapeutics Main Business
5.3.3 Cytori Therapeutics Cord Blood Stem Cells Products, Services and Solutions
5.3.4 Cytori Therapeutics Cord Blood Stem Cells Revenue (US$ Million) & (2018-2023)
5.3.5 Mesoblast Limited Recent Developments
5.4 Mesoblast Limited
5.4.1 Mesoblast Limited Profile
5.4.2 Mesoblast Limited Main Business
5.4.3 Mesoblast Limited Cord Blood Stem Cells Products, Services and Solutions
5.4.4 Mesoblast Limited Cord Blood Stem Cells Revenue (US$ Million) & (2018-2023)
5.4.5 Mesoblast Limited Recent Developments
5.5 Opexa Therapeutics Inc.
5.5.1 Opexa Therapeutics Inc. Profile
5.5.2 Opexa Therapeutics Inc. Main Business
5.5.3 Opexa Therapeutics Inc. Cord Blood Stem Cells Products, Services and Solutions
5.5.4 Opexa Therapeutics Inc. Cord Blood Stem Cells Revenue (US$ Million) & (2018-2023)
5.5.5 Opexa Therapeutics Inc. Recent Developments
5.6 Athersys Inc.
5.6.1 Athersys Inc. Profile
5.6.2 Athersys Inc. Main Business
5.6.3 Athersys Inc. Cord Blood Stem Cells Products, Services and Solutions
5.6.4 Athersys Inc. Cord Blood Stem Cells Revenue (US$ Million) & (2018-2023)
5.6.5 Athersys Inc. Recent Developments
5.7 Geron Corporation
5.7.1 Geron Corporation Profile
5.7.2 Geron Corporation Main Business
5.7.3 Geron Corporation Cord Blood Stem Cells Products, Services and Solutions
5.7.4 Geron Corporation Cord Blood Stem Cells Revenue (US$ Million) & (2018-2023)
5.7.5 Geron Corporation Recent Developments
5.8 Neostem Inc.
5.8.1 Neostem Inc. Profile
5.8.2 Neostem Inc. Main Business
5.8.3 Neostem Inc. Cord Blood Stem Cells Products, Services and Solutions
5.8.4 Neostem Inc. Cord Blood Stem Cells Revenue (US$ Million) & (2018-2023)
5.8.5 Neostem Inc. Recent Developments
5.9 CBR Systems, Inc.
5.9.1 CBR Systems, Inc. Profile
5.9.2 CBR Systems, Inc. Main Business
5.9.3 CBR Systems, Inc. Cord Blood Stem Cells Products, Services and Solutions
5.9.4 CBR Systems, Inc. Cord Blood Stem Cells Revenue (US$ Million) & (2018-2023)
5.9.5 CBR Systems, Inc. Recent Developments
5.10 Cordlife
5.10.1 Cordlife Profile
5.10.2 Cordlife Main Business
5.10.3 Cordlife Cord Blood Stem Cells Products, Services and Solutions
5.10.4 Cordlife Cord Blood Stem Cells Revenue (US$ Million) & (2018-2023)
5.10.5 Cordlife Recent Developments
5.11 Cryo-Cell
5.11.1 Cryo-Cell Profile
5.11.2 Cryo-Cell Main Business
5.11.3 Cryo-Cell Cord Blood Stem Cells Products, Services and Solutions
5.11.4 Cryo-Cell Cord Blood Stem Cells Revenue (US$ Million) & (2018-2023)
5.11.5 Cryo-Cell Recent Developments
5.12 Cryo-Save AG (A Group of Esperite)
5.12.1 Cryo-Save AG (A Group of Esperite) Profile
5.12.2 Cryo-Save AG (A Group of Esperite) Main Business
5.12.3 Cryo-Save AG (A Group of Esperite) Cord Blood Stem Cells Products, Services and Solutions
5.12.4 Cryo-Save AG (A Group of Esperite) Cord Blood Stem Cells Revenue (US$ Million) & (2018-2023)
5.12.5 Cryo-Save AG (A Group of Esperite) Recent Developments
5.13 Lifecell
5.13.1 Lifecell Profile
5.13.2 Lifecell Main Business
5.13.3 Lifecell Cord Blood Stem Cells Products, Services and Solutions
5.13.4 Lifecell Cord Blood Stem Cells Revenue (US$ Million) & (2018-2023)
5.13.5 Lifecell Recent Developments
5.14 Stemcyte
5.14.1 Stemcyte Profile
5.14.2 Stemcyte Main Business
5.14.3 Stemcyte Cord Blood Stem Cells Products, Services and Solutions
5.14.4 Stemcyte Cord Blood Stem Cells Revenue (US$ Million) & (2018-2023)
5.14.5 Stemcyte Recent Developments
5.15 Viacord
5.15.1 Viacord Profile
5.15.2 Viacord Main Business
5.15.3 Viacord Cord Blood Stem Cells Products, Services and Solutions
5.15.4 Viacord Cord Blood Stem Cells Revenue (US$ Million) & (2018-2023)
5.15.5 Viacord Recent Developments
5.16 Smart Cells International Ltd.
5.16.1 Smart Cells International Ltd. Profile
5.16.2 Smart Cells International Ltd. Main Business
5.16.3 Smart Cells International Ltd. Cord Blood Stem Cells Products, Services and Solutions
5.16.4 Smart Cells International Ltd. Cord Blood Stem Cells Revenue (US$ Million) & (2018-2023)
5.16.5 Smart Cells International Ltd. Recent Developments
5.17 Cryoviva India
5.17.1 Cryoviva India Profile
5.17.2 Cryoviva India Main Business
5.17.3 Cryoviva India Cord Blood Stem Cells Products, Services and Solutions
5.17.4 Cryoviva India Cord Blood Stem Cells Revenue (US$ Million) & (2018-2023)
5.17.5 Cryoviva India Recent Developments
5.18 Cordvida
5.18.1 Cordvida Profile
5.18.2 Cordvida Main Business
5.18.3 Cordvida Cord Blood Stem Cells Products, Services and Solutions
5.18.4 Cordvida Cord Blood Stem Cells Revenue (US$ Million) & (2018-2023)
5.18.5 Cordvida Recent Developments
5.19 China Cord Blood Corporation
5.19.1 China Cord Blood Corporation Profile
5.19.2 China Cord Blood Corporation Main Business
5.19.3 China Cord Blood Corporation Cord Blood Stem Cells Products, Services and Solutions
5.19.4 China Cord Blood Corporation Cord Blood Stem Cells Revenue (US$ Million) & (2018-2023)
5.19.5 China Cord Blood Corporation Recent Developments
6 North America
6.1 North America Cord Blood Stem Cells Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Cord Blood Stem Cells Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Cord Blood Stem Cells Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Cord Blood Stem Cells Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Cord Blood Stem Cells Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Cord Blood Stem Cells Market Dynamics
11.1 Cord Blood Stem Cells Industry Trends
11.2 Cord Blood Stem Cells Market Drivers
11.3 Cord Blood Stem Cells Market Challenges
11.4 Cord Blood Stem Cells Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
